Insights with Celegence COO Punya Abbhi featured in The Journal of mHealth

Our COO Punya Abbhi shares valuable perspectives in The Journal of mHealth on how Generative AI (GenAI) technology is revolutionizing pharmaceuitcal medical writing and the impact it could have.

Article highlights:

• A new study conducted by Celegence and RAPS reveals that more than half (57%) plan to invest in medical writing over the next year
• Pharmaceutical organizations share concerns about having enough knowledge on how to best deploy AI technologies themselves
• Opportunities to explore AI with controlled experimentation and targeted partnerships can ease the burden and prevent companies from falling behind

Read the full article in The Journal of mHealth.

Celegence has proven experience with medical writing for regulatory submissions. Our deep regulatory expertise, combined with advanced AI-Enabled technology solutions, positions us uniquely to handle the complexities of medical writing. We ensure that every document is not only compliant but crafted to expedite approval processes and facilitate market access. For more information about our services can benefit your regulatory processes, contact us today.